πŸ‡ΊπŸ‡Έ FDA
Patent

US 9272028

Norovirus vaccine formulations

granted A61KA61K2039/5258A61K2039/54

Quick answer

US patent 9272028 (Norovirus vaccine formulations) held by Takeda Vaccines, Inc. expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5258, A61K2039/54, A61K2039/543, A61K2039/55572